Mortality for pancreatic cancer among aluminium smelter workers in Sardinia, Italy

Giornale Italiano di Medicina del Lavoro ed Ergonomia

Volumn 26, Issue 2, 2004, Pages 83-89

  Carta, Plinio ^a   Aru, G ^a   Cadeddu, C ^a   Gigli, G ^a   Papi, G ^b   Carta, F ^b   Nurchis, P ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b ALCOA INC   (United States)

^c ASL 7   (Italy)

Author keywords

Aluminium industry; Diabetes; Pancreatic cancer; Polycyclic aromatic hydrocarbons

Indexed keywords

ALUMINUM; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGRICULTURAL WORKER; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; DIABETES MELLITUS; ENVIRONMENTAL MONITORING; FOLLOW UP; HUMAN; ITALY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PANCREAS CANCER; RISK FACTOR; SMELTER; SMOKING; WORK ENVIRONMENT;

ADULT; ALUMINUM; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; ITALY; MALE; METALLURGY; OCCUPATIONAL DISEASES; PANCREATIC NEOPLASMS;

EID: 3543103785     PISSN: 15927830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Biørseth A, Biørseth O, Fjeldstad PE. Polyciclic aromatic hydrocarbons in the work atmosphere. Determination in an aluminium reduction plant. Scand J Work Environ Health 1978; 4: 212-23.
2. Biørseth A, Biørseth O, Fjeldstad PE. Polyciclic aromatic hydrocarbons in the work atmosphere. Determination of area specific concentrations and job-specific exposure in a vertical pin Söderberg aluminium plant. Scand J Work Environ Health 1981; 7: 223-32.
3. Lindstedt G, Sollemberg J. Polyciclic aromatic hydrocarbons in the occupational environment, with special reference to benzo[a]pyrene measurements in Swedish industry. Scand J Work Environ Health 1982; 8: 1-19.
4. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol 34. Polynuclear aromatic compounds, part 3: aluminium production. Lyon: IARC, 1984.
5. Armstrong B, Tremblay Cg, Cyr D, et al. Estimating the relationship between exposure to tar volatiles and the incidence of bladder cancer in aluminium smelter workers. Scand J Work Environ Health 1986; 12: 486-493.
6. Armstrong B, Tremblay C, Baris D, et al. Lung cancer mortality and polynuclear aromatic hydrocarbons: a case-cohort study of aluminium production workers in Arvida, Quebec, Canada. Am J Epidemiol 1994; 139: 250-262.
7. Spinelli JJ, Band PR, Svirchev L, et al. Mortality and cancer incidence in aluminum reduction plant workers. J Occup Med 1991; 33: 1150-1155.
8. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol 32. Polynuclear aromatic compounds. part 1: chemical environmental and experimental data. Lyon: IARC, 1983.
9. Theriault G, De Guire I, Cordier S. Reducing aluminium: an occupation possibly associated with bladder cancer. Can Med Assoc J 1981; 124: 419-23.
10. Gibbs GW. Mortality of aluminium reduction plant workers, 1950 through 1977. J Occup Med 1985; 25: 761-770.
11. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks of chemicals to humans. Overall evaluation of carcinogenicity: An updating of IARC monographs volumes 1 to 42. Supplement 7, Lyon: IARC, 1987.
12. Rockette HE, Arena VC. Mortality studies of aluminum reduction plant workers: potroom and carbon department. J Occup Med 1983; 25: 549-557.
13. Ambramson MJ, Wlodarczyk JK, Saunders NA, et al. Does aluminium smelting cause lung disease? Am Rev Respir Dis 1989; 139: 1042-1057.
14. Rønneberg A, Andersen A. Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes - part II: cancer morbidity. Occup Environ Med 1995; 52: 250-254.
15. Rønneberg A, Langmark F. Epidemiologic evidence of cancer in aluminum reduction plant workers. Am J Ind Med 1992; 22: 573-590.
16. Tremblay C, Armstrong B, Thériault G, et al. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry. Am J Ind Med 1995; 27: 335-348.
17. Carta P, Cocco PL, Flore C, et al. Mortality in workers of a primary aluminium foundry in Portovesme, Sardinia. Med Lav 1992; 85: 530-535.
18. th International Conference on Epidemiology in Occupational Health. Herzliya, Israel, 1999; 1 vol, page 70.
19. National Institute of Occupational Safety and Health (NIOSH): Polynuclear aromatic hydrocarbons by HPLC: Method No 5506, Issue 2, NIOSH manual of analytical methods (NMAM), fourth edition, NIOSH, Cincinnati, OH/8/45/4994, USA
20. Jongeneelen FJ, Anzion RBM, Henderson PT. Determination of Hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. J Chromatogr 1987; 413: 227-32.
21. Assennato G, Ferri GM, Foà V, et al. Correlation between PAH airborne concentration and PAH-DNA adducts levels in coke-oven workers. Int Arch Occup Environ Health 1993; 65: S143-S145.
22. Moulin JJ, Clavel T, Buclez B, et al. A mortality study among workers in a French aluminium reduction plant. Int Arch Occup Environ Health 2000; 73: 323-330.
23. Romundstad P, Haldorsen T, Andersen A. Lung and bladder cancer among workers in a Noerwegian aluminium plant. Occup Environ Health 2000; 57: 495-499.
24. Rønneberg A, Haldorsen T, Romundstad P, et al. Occupational exposure and cancer incidence among workers from an aluminum smelter in western Norway. Scan J Work Environ Health 1999; 25: 207-214.
25. Romundstad P, Haldorsen T, Andersen A. Cancer incidence and cause specific mortality among workers in two Norwegian aluminum reduction plants. Am J Ind Med 2000; 37: 175-183.
26. Romundstad P, Andersen A, Haldorsen T. Cancer incidence among workers in six Norwegian aluminum plants. Scan J Work Environ Health 2000; 26: 461-469.
27. Boffetta P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997; 8: 444-472.
28. Axelson O. Aspects of confounding in occupational health epidemiology. Scan J Work Environ Health 1978; 4: 461-469.
29. Axelson O, Steenland K. Indirect methods of assessing the effects of tobacco use in occupational studies. Am J Ind Med 1988; 13: 175-183.
30. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol 38. Tobacco smoking. Lyon: IARC, 1986.
31. Milham S. Mortality in aluminium reduction plant workers. J Occup Med 1979; 21: 475-480.
32. Mur JM, Moulin JJ, Meyer-Bisch C, et al. Mortality of aluminium reduction plant workers in France. Int J Epidemiol 1987; 16: 257-264.
33. Ojajärvi IA, Partanen TJ, Ahlbom A, et al. Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med 2000; 57: 316-324.
34. Alguacil J, Kauppinen T, Porta et al. Risk of pancreatic cancer and occupational exposures in Spain. Ann Occup Hygen 2000; 44: 391-403.
35. Ji BT, Silverman DT, Stewart PA, et al. Occupational exposure to pesticides and pancreatic cancer. Am J Ind Med 2001; 39: 92-99.
36. Keman GJ, Ji BT, Dosemeci M, et al. Occupational risk factors for pancreatic cancer: a case-control study based on death certificates from 24 U.S. states. Am J Ind Med 1999; 36: 260-270.
37. Weiderpass E, Partanen T, Kaas R, et al. Occurence, trends and environmental etiology of pancreatic cancer. Scan J Work Environ Health 1998; 24: 165-174.
38. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. JAMA 1995; 273: 1605-1609.
39. Taylor WF, Everhart JE. Pancreatic cancer. In: Everhart IE, ed. Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC: US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994: 247-270. NIH publication 94-1447.
40. Permert J, Ishe I, Jorfeldt L, et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993; 159: 101-107.
41. Permert J, Larsson J, Ishe I, et al. Diagnosis of pancreatic cancer: alteration of glucose metabolism. Int J Pancreatol 1991; 9: 113-117.
42. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 1981; 122: 158-167.
43. Gullo L, Pezzilli R, Morselli-Labate AM, for the Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994; 331: 81-84.
44. Balkau B, Barret-Connor E, Eschwege E, et al. Diabetes and pancreatic cancer. Diabete Metab 1993; 19: 458-462.
45. Muntoni S, Songini M. High incidence rate of IDDM in Sardinia. Sardinian collaborative group for epidemiology of IDDM. Diabets Care 1992; 15: 1317-1322.